Diamyd Medical AB (publ)
DYMDF
$0.73
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 38.80K | 35.60K | 12.10K | 12.00K | 16.90K |
| Total Other Revenue | 200.00 | 200.00 | 200.00 | 0.00 | 0.00 |
| Total Revenue | 39.00K | 35.80K | 12.30K | 12.00K | 16.90K |
| Cost of Revenue | 358.30K | 369.60K | 373.30K | 377.20K | 369.00K |
| Gross Profit | -319.30K | -333.80K | -361.00K | -365.20K | -352.20K |
| SG&A Expenses | 6.80M | 5.95M | 5.55M | 5.11M | 4.69M |
| Depreciation & Amortization | 738.30K | 683.80K | 639.50K | 596.10K | 563.70K |
| Other Operating Expenses | -355.50K | -356.90K | -296.00K | -343.80K | -259.30K |
| Total Operating Expenses | 22.17M | 19.12M | 18.00M | 17.57M | 16.54M |
| Operating Income | -22.13M | -19.09M | -17.99M | -17.56M | -16.52M |
| Income Before Tax | -21.29M | -18.41M | -16.67M | -16.72M | -16.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -21.29 | -18.41 | -16.67 | -16.72 | -16.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -21.29M | -18.41M | -16.67M | -16.72M | -16.02M |
| EBIT | -22.13M | -19.09M | -17.99M | -17.56M | -16.52M |
| EBITDA | -21.40M | -18.41M | -17.35M | -16.95M | -15.95M |
| EPS Basic | -0.16 | -0.15 | -0.15 | -0.16 | -0.16 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| EPS Diluted | -0.16 | -0.15 | -0.15 | -0.16 | -0.16 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.10 | -0.10 | -0.10 |
| Average Basic Shares Outstanding | 518.40M | 484.99M | 449.81M | 412.03M | 402.73M |
| Average Diluted Shares Outstanding | 518.40M | 484.99M | 449.81M | 412.03M | 402.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |